HEADER ISOMERASE 11-SEP-13 4MO2 TITLE CRYSTAL STRUCTURE OF UDP-N-ACETYLGALACTOPYRANOSE MUTASE FROM TITLE 2 CAMPYLOBACTER JEJUNI COMPND MOL_ID: 1; COMPND 2 MOLECULE: UDP-GALACTOPYRANOSE MUTASE; COMPND 3 CHAIN: B, A; COMPND 4 EC: 5.4.99.9; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CAMPYLOBACTER JEJUNI SUBSP. JEJUNI; SOURCE 3 ORGANISM_TAXID: 192222; SOURCE 4 STRAIN: 11168; SOURCE 5 GENE: CJ1439C, GLF; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH5ALPHA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PWM1007 KEYWDS UDP-N-ACETYLGALACTOPYRANOSE MUTASE, UNGM, CAPSULAR POLYSACCHARIDES, KEYWDS 2 BIFUNCTIONAL, DRUG TARGET, FAD, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.A.DALRYMPLE,C.PROTSKO,M.B.POULIN,T.L.LOWARY,D.A.R.SANDERS REVDAT 3 28-FEB-24 4MO2 1 REMARK REVDAT 2 15-NOV-17 4MO2 1 REMARK REVDAT 1 01-JAN-14 4MO2 0 JRNL AUTH M.B.POULIN,Y.SHI,C.PROTSKO,S.A.DALRYMPLE,D.A.SANDERS, JRNL AUTH 2 B.M.PINTO,T.L.LOWARY JRNL TITL SPECIFICITY OF A UDP-GALNAC PYRANOSE-FURANOSE MUTASE: A JRNL TITL 2 POTENTIAL THERAPEUTIC TARGET FOR CAMPYLOBACTER JEJUNI JRNL TITL 3 INFECTIONS. JRNL REF CHEMBIOCHEM V. 15 47 2014 JRNL REFN ISSN 1439-4227 JRNL PMID 24302429 JRNL DOI 10.1002/CBIC.201300653 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.51 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 63959 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3199 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.5251 - 5.6847 1.00 2882 152 0.1877 0.1800 REMARK 3 2 5.6847 - 4.5132 1.00 2721 143 0.1513 0.1874 REMARK 3 3 4.5132 - 3.9430 1.00 2704 143 0.1334 0.1634 REMARK 3 4 3.9430 - 3.5827 1.00 2667 140 0.1381 0.1738 REMARK 3 5 3.5827 - 3.3259 1.00 2674 141 0.1521 0.2000 REMARK 3 6 3.3259 - 3.1299 1.00 2657 140 0.1600 0.1867 REMARK 3 7 3.1299 - 2.9732 1.00 2621 138 0.1651 0.1884 REMARK 3 8 2.9732 - 2.8438 1.00 2639 139 0.1741 0.2131 REMARK 3 9 2.8438 - 2.7343 1.00 2636 138 0.1746 0.2566 REMARK 3 10 2.7343 - 2.6400 1.00 2652 140 0.1750 0.2186 REMARK 3 11 2.6400 - 2.5574 1.00 2594 136 0.1710 0.2389 REMARK 3 12 2.5574 - 2.4843 1.00 2654 140 0.1782 0.2232 REMARK 3 13 2.4843 - 2.4189 1.00 2585 136 0.1754 0.2306 REMARK 3 14 2.4189 - 2.3599 1.00 2639 139 0.1833 0.2331 REMARK 3 15 2.3599 - 2.3063 1.00 2606 137 0.1877 0.2391 REMARK 3 16 2.3063 - 2.2572 1.00 2623 138 0.1884 0.2474 REMARK 3 17 2.2572 - 2.2120 1.00 2592 137 0.1947 0.2925 REMARK 3 18 2.2120 - 2.1703 1.00 2623 138 0.2024 0.2659 REMARK 3 19 2.1703 - 2.1315 1.00 2607 137 0.2095 0.2640 REMARK 3 20 2.1315 - 2.0954 1.00 2586 136 0.2115 0.2352 REMARK 3 21 2.0954 - 2.0616 1.00 2640 139 0.2191 0.2866 REMARK 3 22 2.0616 - 2.0299 1.00 2579 136 0.2317 0.2590 REMARK 3 23 2.0299 - 2.0000 1.00 2579 136 0.2478 0.3363 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.320 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.51 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 6408 REMARK 3 ANGLE : 0.670 8675 REMARK 3 CHIRALITY : 0.051 880 REMARK 3 PLANARITY : 0.002 1092 REMARK 3 DIHEDRAL : 14.323 2423 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MO2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1000082152. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9790 REMARK 200 MONOCHROMATOR : ACCEL/BRUKER DOUBLE CRYSTAL REMARK 200 MONOCHROMATOR (DCM), FEATURING REMARK 200 INDIRECTLY CRYO-COOLED FIRST REMARK 200 CRYSTAL AND SAGITTALLY FOCUSING REMARK 200 SECOND CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XSCALE REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63966 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 47.510 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.110 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.5500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.83000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.510 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM ACETATE, 0.1M TRI-SODIUM REMARK 280 CITRATE PH 5.6, 25%(W/V) PEG 4000, MICROBATCH, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.21000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.62000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.07500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 82.62000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.21000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.07500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -54.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 24.21000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 -82.62000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -42.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS B 366 REMARK 465 GLN B 367 REMARK 465 GLY B 368 REMARK 465 LYS A 364 REMARK 465 ASN A 365 REMARK 465 LYS A 366 REMARK 465 GLN A 367 REMARK 465 GLY A 368 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 76 -169.66 -79.93 REMARK 500 LYS B 87 -114.78 54.64 REMARK 500 PHE B 95 98.26 -65.38 REMARK 500 LYS B 107 -37.94 -137.50 REMARK 500 ILE B 147 -50.50 -122.37 REMARK 500 TYR B 174 49.09 -95.48 REMARK 500 TYR B 236 34.37 -97.57 REMARK 500 TYR B 309 -63.57 -100.16 REMARK 500 LYS B 364 -94.06 -115.15 REMARK 500 LYS A 87 -114.30 52.99 REMARK 500 PHE A 95 98.91 -65.40 REMARK 500 LYS A 107 -31.78 -132.89 REMARK 500 TYR A 174 47.25 -94.36 REMARK 500 ASP A 177 112.97 -160.97 REMARK 500 ASN A 221 41.64 36.10 REMARK 500 TYR A 309 -62.28 -97.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FDA B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 405 DBREF 4MO2 B 1 368 UNP Q0P8H5 Q0P8H5_CAMJE 1 368 DBREF 4MO2 A 1 368 UNP Q0P8H5 Q0P8H5_CAMJE 1 368 SEQRES 1 B 368 MET TYR ASP TYR LEU ILE VAL GLY SER GLY LEU PHE GLY SEQRES 2 B 368 SER ILE PHE ALA TYR GLU ALA THR GLU LYS GLY TYR THR SEQRES 3 B 368 CYS LEU VAL VAL GLU GLN ARG GLU HIS ILE GLY GLY ASN SEQRES 4 B 368 CYS TYR THR GLU ASN ILE LYS ASN ILE ASN VAL HIS LYS SEQRES 5 B 368 TYR GLY ALA HIS ILE PHE ARG THR SER ASP GLN ASN ILE SEQRES 6 B 368 TRP ASP TYR MET ASN GLN PHE CYS GLU PHE ASN HIS PHE SEQRES 7 B 368 ILE ASN SER PRO ILE ALA ILE TYR LYS ASP GLU ILE TYR SEQRES 8 B 368 ASN LEU PRO PHE ASN MET ASN THR PHE SER LYS LEU TRP SEQRES 9 B 368 GLY ILE LYS THR PRO ASN GLU ALA ARG LYS ILE ILE GLU SEQRES 10 B 368 MET GLN LYS GLN ILE ILE GLN HIS PRO PRO LYS ASN LEU SEQRES 11 B 368 GLU GLU GLN ALA ILE SER LEU VAL GLY THR ASP VAL TYR SEQRES 12 B 368 GLU LYS LEU ILE LYS GLY TYR THR GLU LYS GLN TRP GLY SEQRES 13 B 368 ARG SER CYS LYS ASP LEU PRO ALA SER ILE ILE ARG ARG SEQRES 14 B 368 LEU PRO VAL ARG TYR ILE TYR ASP ASN ASN TYR PHE ASN SEQRES 15 B 368 ASP PRO TYR GLN GLY ILE PRO LYS GLY GLY TYR THR ALA SEQRES 16 B 368 ILE PHE ASP LYS MET LEU LYS LYS SER LYS VAL ILE LEU SEQRES 17 B 368 ASN THR ASP PHE LEU LYS TYR LYS ASP LYS PHE LYS ASN SEQRES 18 B 368 LYS ALA LYS LYS ILE VAL PHE THR GLY CYS ILE ASP ALA SEQRES 19 B 368 TYR TYR ASP TYR ARG TYR GLY ALA LEU GLU TYR ARG SER SEQRES 20 B 368 LEU LYS PHE GLU HIS LYS ILE LEU ASN LEU ASP ASN PHE SEQRES 21 B 368 GLN GLY VAL ALA VAL VAL ASN TYR THR ASP LYS GLU ILE SEQRES 22 B 368 PRO TYR THR ARG ILE ILE GLU HIS LYS HIS PHE GLU PHE SEQRES 23 B 368 GLY ASN THR ASP THR THR VAL ILE SER GLU GLU TYR PRO SEQRES 24 B 368 LEU GLU TRP ILE LYS GLY ILE GLU PRO TYR TYR PRO ILE SEQRES 25 B 368 ASN ASP GLU LYS ASN GLN ALA LEU TYR GLU LYS TYR LYS SEQRES 26 B 368 GLN LEU ALA LYS HIS GLU SER ASN VAL TYR PHE GLY GLY SEQRES 27 B 368 ARG LEU GLY GLU TYR ARG TYR TYR ASP MET GLN ASP VAL SEQRES 28 B 368 VAL ARG SER ALA LEU LEU PHE CYS LYS ASN GLU LEU LYS SEQRES 29 B 368 ASN LYS GLN GLY SEQRES 1 A 368 MET TYR ASP TYR LEU ILE VAL GLY SER GLY LEU PHE GLY SEQRES 2 A 368 SER ILE PHE ALA TYR GLU ALA THR GLU LYS GLY TYR THR SEQRES 3 A 368 CYS LEU VAL VAL GLU GLN ARG GLU HIS ILE GLY GLY ASN SEQRES 4 A 368 CYS TYR THR GLU ASN ILE LYS ASN ILE ASN VAL HIS LYS SEQRES 5 A 368 TYR GLY ALA HIS ILE PHE ARG THR SER ASP GLN ASN ILE SEQRES 6 A 368 TRP ASP TYR MET ASN GLN PHE CYS GLU PHE ASN HIS PHE SEQRES 7 A 368 ILE ASN SER PRO ILE ALA ILE TYR LYS ASP GLU ILE TYR SEQRES 8 A 368 ASN LEU PRO PHE ASN MET ASN THR PHE SER LYS LEU TRP SEQRES 9 A 368 GLY ILE LYS THR PRO ASN GLU ALA ARG LYS ILE ILE GLU SEQRES 10 A 368 MET GLN LYS GLN ILE ILE GLN HIS PRO PRO LYS ASN LEU SEQRES 11 A 368 GLU GLU GLN ALA ILE SER LEU VAL GLY THR ASP VAL TYR SEQRES 12 A 368 GLU LYS LEU ILE LYS GLY TYR THR GLU LYS GLN TRP GLY SEQRES 13 A 368 ARG SER CYS LYS ASP LEU PRO ALA SER ILE ILE ARG ARG SEQRES 14 A 368 LEU PRO VAL ARG TYR ILE TYR ASP ASN ASN TYR PHE ASN SEQRES 15 A 368 ASP PRO TYR GLN GLY ILE PRO LYS GLY GLY TYR THR ALA SEQRES 16 A 368 ILE PHE ASP LYS MET LEU LYS LYS SER LYS VAL ILE LEU SEQRES 17 A 368 ASN THR ASP PHE LEU LYS TYR LYS ASP LYS PHE LYS ASN SEQRES 18 A 368 LYS ALA LYS LYS ILE VAL PHE THR GLY CYS ILE ASP ALA SEQRES 19 A 368 TYR TYR ASP TYR ARG TYR GLY ALA LEU GLU TYR ARG SER SEQRES 20 A 368 LEU LYS PHE GLU HIS LYS ILE LEU ASN LEU ASP ASN PHE SEQRES 21 A 368 GLN GLY VAL ALA VAL VAL ASN TYR THR ASP LYS GLU ILE SEQRES 22 A 368 PRO TYR THR ARG ILE ILE GLU HIS LYS HIS PHE GLU PHE SEQRES 23 A 368 GLY ASN THR ASP THR THR VAL ILE SER GLU GLU TYR PRO SEQRES 24 A 368 LEU GLU TRP ILE LYS GLY ILE GLU PRO TYR TYR PRO ILE SEQRES 25 A 368 ASN ASP GLU LYS ASN GLN ALA LEU TYR GLU LYS TYR LYS SEQRES 26 A 368 GLN LEU ALA LYS HIS GLU SER ASN VAL TYR PHE GLY GLY SEQRES 27 A 368 ARG LEU GLY GLU TYR ARG TYR TYR ASP MET GLN ASP VAL SEQRES 28 A 368 VAL ARG SER ALA LEU LEU PHE CYS LYS ASN GLU LEU LYS SEQRES 29 A 368 ASN LYS GLN GLY HET SO4 B 401 5 HET FDA B 402 53 HET GOL B 403 6 HET GOL A 401 6 HET SO4 A 402 5 HET NH4 A 403 1 HET NH4 A 404 1 HET FAD A 405 53 HETNAM SO4 SULFATE ION HETNAM FDA DIHYDROFLAVINE-ADENINE DINUCLEOTIDE HETNAM GOL GLYCEROL HETNAM NH4 AMMONIUM ION HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 SO4 2(O4 S 2-) FORMUL 4 FDA C27 H35 N9 O15 P2 FORMUL 5 GOL 2(C3 H8 O3) FORMUL 8 NH4 2(H4 N 1+) FORMUL 10 FAD C27 H33 N9 O15 P2 FORMUL 11 HOH *777(H2 O) HELIX 1 1 GLY B 10 LYS B 23 1 14 HELIX 2 2 GLY B 37 CYS B 40 5 4 HELIX 3 3 ASP B 62 ASN B 70 1 9 HELIX 4 4 ASN B 96 GLY B 105 1 10 HELIX 5 5 THR B 108 GLN B 121 1 14 HELIX 6 6 ASN B 129 GLY B 139 1 11 HELIX 7 7 GLY B 139 ILE B 147 1 9 HELIX 8 8 ILE B 147 GLY B 156 1 10 HELIX 9 9 SER B 158 LEU B 162 5 5 HELIX 10 10 PRO B 163 ILE B 167 5 5 HELIX 11 11 TYR B 193 LEU B 201 1 9 HELIX 12 12 ASP B 211 LYS B 214 5 4 HELIX 13 13 TYR B 215 ASN B 221 1 7 HELIX 14 14 CYS B 231 TYR B 236 1 6 HELIX 15 15 LYS B 282 GLU B 285 5 4 HELIX 16 16 ASP B 314 HIS B 330 1 17 HELIX 17 17 GLY B 337 GLU B 342 1 6 HELIX 18 18 ASP B 347 LEU B 363 1 17 HELIX 19 19 GLY A 10 LYS A 23 1 14 HELIX 20 20 GLY A 37 CYS A 40 5 4 HELIX 21 21 ASP A 62 ASN A 70 1 9 HELIX 22 22 ASN A 96 GLY A 105 1 10 HELIX 23 23 THR A 108 GLN A 121 1 14 HELIX 24 24 ASN A 129 GLY A 139 1 11 HELIX 25 25 GLY A 139 ILE A 147 1 9 HELIX 26 26 ILE A 147 GLY A 156 1 10 HELIX 27 27 SER A 158 LEU A 162 5 5 HELIX 28 28 PRO A 163 ILE A 167 5 5 HELIX 29 29 TYR A 193 LEU A 201 1 9 HELIX 30 30 TYR A 215 LYS A 220 5 6 HELIX 31 31 CYS A 231 TYR A 236 1 6 HELIX 32 32 LYS A 282 PHE A 286 5 5 HELIX 33 33 ASP A 314 LYS A 329 1 16 HELIX 34 34 GLY A 337 GLU A 342 1 6 HELIX 35 35 ASP A 347 LEU A 363 1 17 SHEET 1 A 5 LYS B 205 ILE B 207 0 SHEET 2 A 5 CYS B 27 VAL B 30 1 N VAL B 29 O LYS B 205 SHEET 3 A 5 TYR B 2 VAL B 7 1 N ILE B 6 O LEU B 28 SHEET 4 A 5 ALA B 223 PHE B 228 1 O VAL B 227 N LEU B 5 SHEET 5 A 5 VAL B 334 PHE B 336 1 O TYR B 335 N ILE B 226 SHEET 1 B 2 THR B 42 ILE B 45 0 SHEET 2 B 2 ILE B 48 HIS B 51 -1 O ILE B 48 N ILE B 45 SHEET 1 C 2 PHE B 58 THR B 60 0 SHEET 2 C 2 TYR B 185 GLY B 187 -1 O TYR B 185 N THR B 60 SHEET 1 D 7 GLU B 89 ASN B 92 0 SHEET 2 D 7 ILE B 83 TYR B 86 -1 N ALA B 84 O TYR B 91 SHEET 3 D 7 VAL B 265 TYR B 268 1 O ASN B 267 N ILE B 85 SHEET 4 D 7 ARG B 277 GLU B 280 -1 O ILE B 278 N VAL B 266 SHEET 5 D 7 THR B 292 LEU B 300 -1 O GLU B 297 N ARG B 277 SHEET 6 D 7 TYR B 245 LEU B 255 -1 N LYS B 253 O ILE B 294 SHEET 7 D 7 TYR B 310 PRO B 311 -1 O TYR B 310 N ARG B 246 SHEET 1 E 5 LYS A 205 ILE A 207 0 SHEET 2 E 5 CYS A 27 VAL A 30 1 N VAL A 29 O ILE A 207 SHEET 3 E 5 TYR A 2 VAL A 7 1 N ILE A 6 O LEU A 28 SHEET 4 E 5 ALA A 223 PHE A 228 1 O LYS A 225 N LEU A 5 SHEET 5 E 5 VAL A 334 PHE A 336 1 O TYR A 335 N PHE A 228 SHEET 1 F 2 THR A 42 ILE A 45 0 SHEET 2 F 2 ILE A 48 HIS A 51 -1 O ILE A 48 N ILE A 45 SHEET 1 G 2 PHE A 58 THR A 60 0 SHEET 2 G 2 TYR A 185 GLY A 187 -1 O TYR A 185 N THR A 60 SHEET 1 H 7 GLU A 89 ASN A 92 0 SHEET 2 H 7 ILE A 83 TYR A 86 -1 N ALA A 84 O TYR A 91 SHEET 3 H 7 VAL A 265 TYR A 268 1 O ASN A 267 N ILE A 83 SHEET 4 H 7 ARG A 277 GLU A 280 -1 O ILE A 278 N VAL A 266 SHEET 5 H 7 THR A 292 LEU A 300 -1 O GLU A 297 N ARG A 277 SHEET 6 H 7 TYR A 245 LEU A 255 -1 N LYS A 253 O ILE A 294 SHEET 7 H 7 TYR A 310 PRO A 311 -1 O TYR A 310 N ARG A 246 CISPEP 1 LEU B 93 PRO B 94 0 -4.94 CISPEP 2 LEU A 93 PRO A 94 0 -2.90 SITE 1 AC1 7 LYS A 148 LYS A 160 NH4 A 404 LYS B 224 SITE 2 AC1 7 HOH B 830 HOH B 879 HOH B 953 SITE 1 AC2 34 VAL B 7 GLY B 8 GLY B 10 LEU B 11 SITE 2 AC2 34 PHE B 12 VAL B 30 GLU B 31 GLN B 32 SITE 3 AC2 34 ARG B 33 GLY B 38 ASN B 39 ALA B 55 SITE 4 AC2 34 HIS B 56 ILE B 57 ARG B 59 THR B 210 SITE 5 AC2 34 ASP B 211 PHE B 212 GLY B 230 LEU B 248 SITE 6 AC2 34 TYR B 309 TYR B 310 GLY B 338 ARG B 339 SITE 7 AC2 34 TYR B 345 TYR B 346 ASP B 347 MET B 348 SITE 8 AC2 34 HOH B 501 HOH B 504 HOH B 520 HOH B 523 SITE 9 AC2 34 HOH B 711 HOH B 859 SITE 1 AC3 8 ILE A 90 ASN A 92 LYS A 102 HOH A 503 SITE 2 AC3 8 ASN B 98 SER B 101 LYS B 102 TYR B 176 SITE 1 AC4 8 ASN A 98 SER A 101 LYS A 102 TYR A 176 SITE 2 AC4 8 ILE B 90 ASN B 92 LYS B 102 HOH B 505 SITE 1 AC5 7 LYS A 148 GLU A 152 LYS A 271 NH4 A 403 SITE 2 AC5 7 HOH A 534 HOH A 729 LYS B 224 SITE 1 AC6 3 ASP A 270 LYS A 271 SO4 A 402 SITE 1 AC7 5 GLU A 131 CYS A 159 LYS A 160 HOH A 645 SITE 2 AC7 5 SO4 B 401 SITE 1 AC8 37 VAL A 7 GLY A 8 GLY A 10 LEU A 11 SITE 2 AC8 37 PHE A 12 VAL A 30 GLU A 31 GLN A 32 SITE 3 AC8 37 ARG A 33 GLY A 38 ASN A 39 TYR A 53 SITE 4 AC8 37 ALA A 55 HIS A 56 ILE A 57 ARG A 59 SITE 5 AC8 37 THR A 210 ASP A 211 PHE A 212 THR A 229 SITE 6 AC8 37 GLY A 230 LEU A 248 TYR A 309 TYR A 310 SITE 7 AC8 37 GLY A 338 ARG A 339 TYR A 345 TYR A 346 SITE 8 AC8 37 ASP A 347 MET A 348 VAL A 351 HOH A 506 SITE 9 AC8 37 HOH A 515 HOH A 518 HOH A 578 HOH A 582 SITE 10 AC8 37 HOH A 763 CRYST1 48.420 116.150 165.240 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020653 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008610 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006052 0.00000